Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells.
about
Surgery on the Trabecular Meshwork: Histopathological EvidenceProspects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivoPharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptorEnhancement of scleral macromolecular permeability with prostaglandinsThe growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1Effect of diode laser contact transscleral pars plana photocoagulation on intraocular pressure in glaucoma.Aryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.Matricellular proteins in the trabecular meshwork: review and update.Uveoscleral outflow.Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells.Latanoprost-induced changes in rat intraocular pressure: direct or indirect?Effects of prostaglandin analogues on aqueous humor outflow pathways.Prostaglandins in the eye: Function, expression, and roles in glaucoma.Cellular basis for bimatoprost effects on human conventional outflow.An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapyAn evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.Functional dichotomy: glutathione and vitamin E in homeostasis relevant to primary open-angle glaucoma.Characterization of uveoscleral outflow in enucleated porcine eyes perfused under constant pressure.Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, foOcular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes.Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study.Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.The role of endothelin in the pathophysiology of glaucoma.Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression.Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.Can NSAIDs and prostaglandin analogues be combined?Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites.Effect of tafluprost 0.0015% on central corneal thickness in patients with primary open-angle glaucoma.Prostaglandins E1 and E2, but not F2alpha or latanoprost, inhibit monkey ciliary muscle contraction.Prostaglandin E2 receptor subtype EP2- and EP4-regulated gene expression profiling in human ciliary smooth muscle cells.
P2860
Q26753170-2F7A338D-7728-4917-9AD9-8EE4F404C331Q27024271-2ABCFF52-FFC9-4B59-9701-D121A4677E27Q28344632-64243B06-2790-4BEC-96C5-B858A6180EE2Q28345276-D59F9DB3-9208-4CC4-A05E-E91FEE68F3B4Q28363021-096A59FC-F336-4009-AAB3-1F9C0B4B7C41Q33184291-2E5B59E0-8766-4ECF-B497-C9E92D1332B3Q33698322-DEC423D7-B154-4CB1-B719-280493529EB2Q33820048-5CFF5686-FEF7-4312-8336-09AED2F0B82DQ34057640-981213E8-9D93-47A1-ACA7-CFAF247430B6Q34309970-1DCFA92E-C32C-43CD-A59E-3F034B16BCB0Q34309976-723D3987-9195-4638-B17C-E0824E141CF7Q34393424-91396AC6-27BB-4DFD-97FD-96BC931887C7Q34521850-E018093D-0FE2-474A-948F-91E771D4F733Q34735244-D2AC5E9A-D642-491F-BA0F-EF33A3B6D96FQ35125573-FCF342CE-4C61-4534-8E7D-5A7A252EC350Q35753429-F9FD06A7-78C2-4604-8CBA-D0D35183F184Q35795259-F4FE1C57-543D-4620-B98B-606D7FE87ABAQ35920293-4C3F55C0-58E7-4BFB-B231-B0ACA28D1847Q35949978-5CD1FB57-36E3-4363-AA1E-685790CD82F5Q36403804-BC5F3B19-E124-4747-9947-FA0616B6A170Q37079208-53C6C9F3-FC65-4989-AC28-CC538772257EQ37149430-1085D8FB-A93A-4343-B88C-D93DF163DA67Q37452805-CED28893-4B5A-491B-A738-790D94D4696AQ37747485-7FF7A57C-BAA5-4448-94F2-A5258D272A3AQ40651153-BC7AE0F6-387B-415B-A451-68368103A662Q40733252-9D97E2EA-A1D3-42CA-BFB2-AE88FE391864Q41888049-6B104158-9ED2-4981-B6B6-1816628FA5F1Q43208035-C7E3A8A2-DD90-4ED9-9C69-000A9EDECFC4Q43681101-7949DD9E-C91C-4679-94B8-18F9EEA0A595Q43882819-2159448B-6FE6-4D90-B833-7FE8548D5834Q45068040-9A25245A-640B-497F-9B2F-B1DA1C1947E5Q46658201-5C5779A8-1E8B-4761-9C51-48BC43C5310EQ54424215-53CA3CDA-134D-4569-BF6D-8B78EE862E8C
P2860
Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@en
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@nl
type
label
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@en
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@nl
prefLabel
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@en
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@nl
P2093
P2860
P1433
P1476
Prostaglandins increase proMMP ...... n ciliary smooth muscle cells.
@en
P2093
F Kashiwagi
G S Firestein
J D Lindsey
K Kashiwagi
R N Weinreb
P2860
P304
P356
10.3109/02713689609017628
P577
1996-08-01T00:00:00Z